Literature DB >> 21297097

Emergence of raltegravir-resistant HIV-1 in the central nervous system.

K Watanabe1, M Honda, T Watanabe, K Tsukada, K Teruya, Y Kikuchi, S Oka, H Gatanaga.   

Abstract

Integrase inhibitor-resistant HIV-1 was detected in the cerebrospinal fluid, but not in the plasma of a 42-year-old man with HIV encephalopathy treated with a raltegravir (RAL)-containing regimen. Raltegravir resistance may develop in the central nervous system when the virus is already multi-drug resistant because of different penetration into cerebrospinal fluid of individual antiretroviral agents.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21297097     DOI: 10.1258/ijsa.2009.009283

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  2 in total

1.  Raltegravir resistance in the cerebrospinal fluid.

Authors:  B Mora-Peris; N E Mackie; D Suan; D A Cooper; B J Brew; A Winston
Journal:  Infection       Date:  2013-02-03       Impact factor: 3.553

2.  Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected Adults.

Authors:  Shibani S Mukerji; Vikas Misra; David Lorenz; Anna M Cervantes-Arslanian; Jennifer Lyons; Spyridon Chalkias; Alysse Wurcel; Deirdre Burke; Nagagopal Venna; Susan Morgello; Igor J Koralnik; Dana Gabuzda
Journal:  J Acquir Immune Defic Syndr       Date:  2017-06-01       Impact factor: 3.731

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.